VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Linda Kaplan who wrote (3316)	12/10/1997 5:49:00 PM
From: blankmind	Read Replies (1) of 23519

-- Did you read the "Arsenio" release? Or just the headline? -- Was it readable to you or pretty much garbled? -- For instance, "Vivus failed to provide any of the requested information. Asensio & Company believes Vivus' 25% sales drop is a result of poor product performance and early nonrecurring sales to undisclosed sources." You have to ask what in the world they're basing their assumptions on? -- Sorry, but if the product didn't work, how come sales are going thru the roof? And demand outstrip supply? -- Also, I have a friend in the pharm industry. Making a drug in quantity is tough. Plant delays are not uncommon. Their product just started shipment in 12/96; and sales already over $100 mill for the year. -- Out.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next